吉田修
Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Cancer Res. 1992 Apr 1;52(7):1881-5.
Okamoto K, Toyokuni S, Uchida K, Ogawa O, Takenewa J, Kakehi Y, Kinoshita H, Hattori-Nakakuki Y, Hiai H, Yoshida O.
Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma.
Int J Cancer. 1994 Sep 15;58(6):825-9.
Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O.
Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res.
1995 Sep 15;55(18):4182-7.
Okamoto K, Toyokuni S, Kim WJ, Ogawa O, Kakehi Y, Arao S, Hiai H, Yoshida O.
新医師臨床研修制度検討ワーキンググループ委員
医道審議会医師分科会医師臨床研修検討部会委員
新医師臨床研修制度検討ワーキンググループ委員
新医師臨床研修制度施行準備有識者会議委員
日本医師臨床研修マッチング協議会委員
II. Endocrinological analysis.
Urol Res. 1988;16(2):73-8.
Oishi K, Okada K, Yoshida O, Yamabe H, Ohno Y, Hayes RB, Schroeder FH.
Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors.
Prostate. 1989;14(2):117-22.
Arai Y, Yoshiki T, Yoshida O.
Prognostic significance of prostate specific antigen in endocrine treatment for prostatic cancer.
J Urol. 1990 Dec;144(6):1415-9.
Oishi K, Okada K, Yoshida O, Yamabe H, Ohno Y, Hayes RB, Schroeder FH, Boyle P.
A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factors.
Prostate. 1990;17(4):269-79.
de Jong FH, Oishi K, Hayes RB, Bogdanowicz JF, Raatgever JW, van der Maas PJ, Yoshida O, Schroeder FH.